Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Simergent
AddedFeb 17, 2024
UpdatedJun 18, 2026
Simergent

Simergent

Simergent: Innovating home dialysis devices for global markets since 2014.

HQ
Chicago, IL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in 2014, Simergent is dedicated to innovating home dialysis devices for both developed and emerging markets. With a mission to improve the quality of life for patients requiring dialysis, Simergent focuses on creating user-friendly and effective home dialysis solutions. The company operates out of Oklahoma City, OK, and Chicago, IL, aiming to make home dialysis more accessible and convenient for patients worldwide.

Simergent has garnered attention for its impactful contributions to the healthcare sector, particularly in the field of home dialysis. The company has attracted notable investors and industry experts who support its mission to revolutionize dialysis treatment. Through its innovative products, Simergent has significantly improved patient outcomes and accessibility to essential medical care, underscoring its role as a key player in the medical device industry.

Simergent - Similar Companies

Diality logo

Diality

diality.com

Outset Medical logo

Outset Medical

outsetmedical.com

Byonyks Medical Devices logo

Byonyks Medical Devices

byonyks.com

Relavo logo

Relavo

relavomedical.com

Nephrosant logo

Nephrosant

Qidni Labs logo

Qidni Labs

Promedix logo

Promedix

promedixinc.com

Sisu Global Health logo

Sisu Global Health

Phraxis logo

Phraxis

phraxis.com

Remmie logo

Remmie

remmiehealth.com

Pure Life Renal logo

Pure Life Renal

plrenal.com

Healionics logo

Healionics

healionics.com

DaVita logo

DaVita

davita.com

River 3 Renal logo

River 3 Renal

Implantable Artificial Kidney logo

Implantable Artificial Kidney

Simergent - Quick Facts

Who are Simergent's competitors?

Companies similar to Simergent include Diality, Outset Medical, Byonyks Medical Devices and Relavo.

When was Simergent founded?

Simergent was founded in 2014.

Where is Simergent's headquarters located?

Simergent's headquarters is located in Chicago, IL, US.

When was Simergent's last funding round?

Simergent's most recent funding round was for $3M (USD) in April 2019.

How much has Simergent raised to-date?

As of Apr 24, 2019, Simergent has raised a total of $4.2M (USD).

How many employees does Simergent have?

Simergent has 11 employees as of Feb 4, 2024.

Simergent - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Medical Devices
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Home Dialysis
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities